TMX Group Ltd. (LSX:A1J4GR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Williams Other companies: Marvel Biosciences Corp (President, Chief Science Officer and Director · Since at least Oct 21, 2026) | President and Chief Science Officer · Since at least Dec 22, 2025 |
| Amanda Tang | Director, Investor Relations · Since at least Oct 29, 2026 |
| Caterina De Rosa | Director, Investor Relations · Oct 29, 2025 – Nov 4, 2026 · Past |
| Cindy Gray | VP Investor Relations · Nov 3, 2025 – Nov 5, 2026 · Past |
| Claude Tessier | Corporate Director · Since at least Nov 5, 2026 |
| Eric Wetlaufer | interim chief executive officer · Feb 23, 2026 – Nov 5, 2026 · Past |
| John McKenzie | Chief Executive Officer, TMX Group · Since at least Oct 29, 2026 |
| Luc Bertrand | Chair of the Board · Since at least Nov 5, 2026 |
| Mathieu Labrèche | Director, Corporate Communications and Public Affairs · Sep 9, 2026 – Nov 5, 2026 · Past |
| Michael Ptasznik | Corporate Director · Since at least Nov 5, 2026 |
| Monique Mercier | Corporate Director · Since at least Nov 5, 2026 |
| Nicolas Darveau-Garneau | Corporate Director · Since at least Nov 5, 2026 |
| Peter Rockandel | Corporate Director · Since at least Nov 5, 2026 |
| Sahib Mendiratta | PR and Corporate Communications Manager · Oct 16, 2025 – Nov 4, 2026 · Past |
| Stephanie Cuskley | Corporate Director · Since at least Nov 5, 2026 |
| Steve Fray | CFO · Since at least Feb 9, 2026 |
| Tamara Finch | Corporate Director · Since at least Nov 5, 2026 |
| William Linton | Corporate Director · Since at least Nov 5, 2026 |